YCBD.AMEXCbdmd, INC

Form 4: Director William Raines III Receives cbdMD Equity Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director William F. Raines III was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Summary

  • Director William F. Raines III acquired 1,572 restricted stock units (RSUs) of cbdMD, Inc. common stock.
  • The transaction occurred on April 14, 2026.
  • The RSUs represent a contingent right to receive one share of common stock per unit.
  • The grant serves as compensation for board services under the company's equity compensation plan.
  • Following this transaction, the director's total beneficial ownership is 13,676 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation that does not signal a change in company strategy or financial outlook.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.
  • The grant was approved by the Compensation, Corporate Governance and Nominating Committee, ensuring independent oversight.

Negatives

  • None identified; this is a standard director compensation disclosure.

Risks

  • The value of the equity grant is subject to the market performance of YCBD common stock.

Future Outlook

The RSUs will vest in four equal quarterly installments beginning June 30, 2026, and concluding March 31, 2027, contingent upon continued service.

Management Comments

  • The grant was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the consumer goods and wellness sector to ensure long-term alignment between leadership and shareholders.

Comparison to Industry Standards

  • The use of restricted stock units for director compensation is consistent with standard practices for small-cap publicly traded companies.
  • The vesting schedule of one year is standard for director equity grants in the industry.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity CompensationIssuance of restricted stock units to a director under the 2021 or 2025 Equity Compensation Plan.04/14/2026Minimal; standard compensation practice.

Stakeholder Impact

  • Shareholders: Minor dilution impact, though standard for director compensation.

Next Steps

  • Vesting of the first tranche of RSUs on June 30, 2026.

Key Dates

DateDescription
04/14/2026Date of the RSU grant transaction.
04/16/2026Date the Form 4 was signed and filed.
06/30/2026First quarterly vesting date for the RSUs.
03/31/2027Final quarterly vesting date for the RSUs.

Keywords

cbdMD, YCBD, Form 4, Insider Trading, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.